Stents

New Twelve-Month Data Show Efficacy of Pulsar-18 Bare Metal Stent
News | Stents Peripheral | April 28, 2017

April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world...

Tryton Medical, Side Branch Stent, first U.S. commercial case, New York-Presbyterian Hospital, Columbia University Medical Center
News | Stents Bifurcation | March 31, 2017

March 31, 2017 — Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side...

Videos | Stents Bioresorbable | March 30, 2017

Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses...

BVS, Absorb stent, bioresorbable scaffold, ABSORB III data, ABSORB III results
Feature | Stents Bioresorbable | March 21, 2017 | Dave Fornell

 

March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College...

Gore Tigris Vascular Stent, Health Canada approval, PAD, peripheral artery disease
News | Stents Peripheral | March 16, 2017

March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris...

Videos | Stents Bifurcation | March 06, 2017

The Tryton Side Branch Stent became the first bifurcation stent cleared by the FDA in March 2017. The stent is...

tryton side branch stent, dedicated coronary side branch stent

The Tryton Side Branch Stent is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug eluting stent is then placed in the main vessel.

Technology | Stents Bifurcation | March 06, 2017

March 6, 2017 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) for the Tryton...

Biosensors, BioFreedom drug-coated stent, LEADERS FREE II IDE trial, first patient, U.S. pivotal study
News | Stents Drug Eluting | March 03, 2017

March 3, 2017 — Biosensors International Group Ltd. announced in February enrollment of the first patient in LEADERS...

TOBA II BTK clinical trial, Intact Vascular, Tack Endovascular System, CLI, critical limb ischemia, first patient treated
News | Stents Peripheral | March 02, 2017

March 2, 2017 — Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the...

CeloNova Cobra Pzf stent
Technology | Stents | March 02, 2017

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra...

Biotronik, PRO-Kinetic Energy cobalt chromium coronary stent system, FDA approval
Technology | Stents Bare Metal | February 15, 2017

February 15, 2017 — The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U....

Blog | Stents | February 13, 2017

Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent...

Videos | 3-D Printing | February 09, 2017

When a pediatric patient at Children’s Hospital Los Angeles needed a custom-build stent to repair his pulmonary...

Blog | January 30, 2017

DAIC has worked hard to bring useful technology news and resources to our readers. While we conduct reader surveys...

Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable | January 17, 2017 | Dave Fornell

One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable...

Overlay Init